|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.130 MYR | -2.19% |
|
-2.19% | -1.57% |
| Apr. 14 | Southern Acids (M) Berhad Reports Group Production Results for the Month of March 2026 | CI |
| Apr. 14 | Southern Acids (M) posts Mar palm kernel production 1,852 metric tonne | RE |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.97 | 10.58 | 4.87 | 2.79 | 4.54 | |||||
Return on Total Capital | 5.52 | 12.01 | 5.48 | 3.12 | 5.1 | |||||
Return On Equity % | 7.03 | 15.41 | 6.37 | 2.81 | 5.79 | |||||
Return on Common Equity | 6.06 | 13.83 | 4.49 | 1.78 | 4.71 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 27.85 | 25.19 | 22.13 | 20.45 | 21.74 | |||||
SG&A Margin | 9.3 | 6.5 | 7.35 | 8.86 | 7.95 | |||||
EBITDA Margin % | 10.92 | 14.62 | 8.91 | 7.39 | 8.9 | |||||
EBITA Margin % | 8.17 | 12.75 | 6.84 | 4.84 | 6.66 | |||||
EBIT Margin % | 8.17 | 12.75 | 6.84 | 4.84 | 6.66 | |||||
Income From Continuing Operations Margin % | 6.41 | 10 | 4.88 | 2.67 | 4.61 | |||||
Net Income Margin % | 5.01 | 8 | 3.01 | 1.48 | 3.32 | |||||
Net Avail. For Common Margin % | 5.01 | 8 | 3.01 | 1.48 | 3.32 | |||||
Normalized Net Income Margin | 3.66 | 5.92 | 2.36 | 1.75 | 2.79 | |||||
Levered Free Cash Flow Margin | 2.86 | 3.36 | 8.2 | 1.52 | 1.85 | |||||
Unlevered Free Cash Flow Margin | 2.9 | 3.41 | 8.25 | 1.58 | 1.96 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.97 | 1.33 | 1.14 | 0.92 | 1.09 | |||||
Fixed Assets Turnover | 3.83 | 5.95 | 5.52 | 4.43 | 5.27 | |||||
Receivables Turnover (Average Receivables) | 15.83 | 18.65 | 16.75 | 15.12 | 19.28 | |||||
Inventory Turnover (Average Inventory) | 7.15 | 9.07 | 8.55 | 8.79 | 10.69 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 6.18 | 5.14 | 7.77 | 5.97 | 6.56 | |||||
Quick Ratio | 4.84 | 3.96 | 6.45 | 5.01 | 5.38 | |||||
Operating Cash Flow to Current Liabilities | 0.69 | 0.74 | 1.46 | 0.27 | 0.55 | |||||
Days Sales Outstanding (Average Receivables) | 23.06 | 19.57 | 21.79 | 24.21 | 18.93 | |||||
Days Outstanding Inventory (Average Inventory) | 51.02 | 40.24 | 42.7 | 41.63 | 34.14 | |||||
Average Days Payable Outstanding | 17.91 | 13.17 | 12.28 | 14.03 | 12.8 | |||||
Cash Conversion Cycle (Average Days) | 56.17 | 46.65 | 52.22 | 51.82 | 40.27 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 1.34 | 3.08 | 0.81 | 2.82 | 2.1 | |||||
Total Debt / Total Capital | 1.32 | 2.99 | 0.8 | 2.75 | 2.06 | |||||
LT Debt/Equity | 0.93 | 0.47 | 0.48 | 0.24 | 0.14 | |||||
Long-Term Debt / Total Capital | 0.92 | 0.45 | 0.47 | 0.23 | 0.14 | |||||
Total Liabilities / Total Assets | 12.02 | 14.99 | 10.5 | 13.76 | 12.4 | |||||
EBIT / Interest Expense | 129.34 | 187.8 | 81.49 | 55.1 | 37.89 | |||||
EBITDA / Interest Expense | 175.88 | 217.18 | 107.68 | 85.87 | 51.33 | |||||
(EBITDA - Capex) / Interest Expense | 127.13 | 191.72 | 79.91 | 43.95 | 31.49 | |||||
Total Debt / EBITDA | 0.11 | 0.15 | 0.07 | 0.36 | 0.19 | |||||
Net Debt / EBITDA | -2.81 | -1.7 | -3.78 | -5.36 | -3.67 | |||||
Total Debt / (EBITDA - Capex) | 0.16 | 0.16 | 0.09 | 0.7 | 0.3 | |||||
Net Debt / (EBITDA - Capex) | -3.89 | -1.93 | -5.1 | -10.48 | -5.99 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 11.98 | 58.31 | -6.28 | -16.85 | 20.19 | |||||
Gross Profit, 1 Yr. Growth % | 2.58 | 43.17 | -17.66 | -23.17 | 27.79 | |||||
EBITDA, 1 Yr. Growth % | 19.87 | 111.97 | -42.92 | -31.01 | 44.73 | |||||
EBITA, 1 Yr. Growth % | 23.32 | 147.24 | -49.74 | -41.19 | 65.52 | |||||
EBIT, 1 Yr. Growth % | 23.32 | 147.24 | -49.74 | -41.19 | 65.52 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 21.81 | 147.2 | -54.31 | -54.53 | 107.66 | |||||
Net Income, 1 Yr. Growth % | 16.75 | 152.75 | -64.74 | -59.05 | 169.19 | |||||
Normalized Net Income, 1 Yr. Growth % | 17.47 | 156.36 | -62.64 | -38.5 | 92.28 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 16.75 | 152.75 | -64.74 | -59.05 | 169.19 | |||||
Accounts Receivable, 1 Yr. Growth % | 25.81 | 41.86 | -22.52 | 9.54 | -19.88 | |||||
Inventory, 1 Yr. Growth % | 21.05 | 36.43 | -20.59 | -13.41 | 9.5 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.97 | -0.44 | 2.63 | 4.63 | -2.57 | |||||
Total Assets, 1 Yr. Growth % | 10.84 | 19.45 | 0.44 | 4.75 | -1.08 | |||||
Tangible Book Value, 1 Yr. Growth % | 7.27 | 14.08 | 3.77 | 3.26 | 0.02 | |||||
Common Equity, 1 Yr. Growth % | 7.27 | 14.08 | 3.77 | 3.26 | 0.02 | |||||
Cash From Operations, 1 Yr. Growth % | 60.5 | 75.59 | 29.86 | -74.7 | 83.16 | |||||
Capital Expenditures, 1 Yr. Growth % | 44.95 | -11.06 | 26.32 | 31.33 | 13.89 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 92.49 | 86.25 | 128.46 | -84.55 | 45.42 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 90.74 | 86.03 | 127.06 | -84.09 | 48.73 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 11.14 | 33.15 | 21.81 | -11.72 | -0.03 | |||||
Gross Profit, 2 Yr. CAGR % | 3.12 | 21.19 | 8.58 | -20.46 | -0.91 | |||||
EBITDA, 2 Yr. CAGR % | 22.51 | 59.4 | 9.99 | -37.25 | -0.06 | |||||
EBITA, 2 Yr. CAGR % | 25.76 | 74.61 | 11.48 | -45.63 | -1.34 | |||||
EBIT, 2 Yr. CAGR % | 25.76 | 74.61 | 11.48 | -45.63 | -1.34 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 36.97 | 73.52 | 6.28 | -54.42 | -2.83 | |||||
Net Income, 2 Yr. CAGR % | 31.86 | 71.78 | -5.6 | -62 | 5 | |||||
Normalized Net Income, 2 Yr. CAGR % | 16.45 | 73.53 | -2.14 | -52.07 | 8.74 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 31.86 | 71.78 | -5.6 | -62 | 5 | |||||
Accounts Receivable, 2 Yr. CAGR % | 20.5 | 33.59 | 4.84 | -7.87 | -6.31 | |||||
Inventory, 2 Yr. CAGR % | 12.71 | 28.51 | 4.09 | -17.08 | -2.63 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 0.79 | 1.74 | 1.08 | 3.62 | 0.96 | |||||
Total Assets, 2 Yr. CAGR % | 4.98 | 15.39 | 9.53 | 2.57 | 1.79 | |||||
Tangible Book Value, 2 Yr. CAGR % | 2.98 | 10.63 | 8.81 | 3.52 | 1.63 | |||||
Common Equity, 2 Yr. CAGR % | 2.98 | 10.63 | 8.81 | 3.52 | 1.63 | |||||
Cash From Operations, 2 Yr. CAGR % | -14.67 | 69.05 | 51 | -42.68 | -31.93 | |||||
Capital Expenditures, 2 Yr. CAGR % | -23.24 | 13.54 | 5.99 | 28.8 | 22.3 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 8.61 | 89.34 | 106.28 | -40.58 | -52.57 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 9.29 | 88.37 | 105.52 | -39.9 | -51.33 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 0 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.93 | 25.05 | 18.44 | 7.25 | -2.16 | |||||
Gross Profit, 3 Yr. CAGR % | 1.31 | 15.04 | 6.54 | -3.25 | -6.84 | |||||
EBITDA, 3 Yr. CAGR % | 7.04 | 47.08 | 13.19 | -5.84 | -17.08 | |||||
EBITA, 3 Yr. CAGR % | 6.27 | 57.54 | 15.29 | -9.92 | -21.2 | |||||
EBIT, 3 Yr. CAGR % | 6.27 | 57.54 | 15.29 | -9.92 | -21.2 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 8.86 | 66.77 | 11.22 | -19.92 | -24.44 | |||||
Net Income, 3 Yr. CAGR % | 4.69 | 63.8 | 1.33 | -28.54 | -27.02 | |||||
Normalized Net Income, 3 Yr. CAGR % | -0.15 | 51.49 | 4.01 | -16.18 | -23.84 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 4.69 | 63.8 | 1.33 | -28.54 | -27.02 | |||||
Accounts Receivable, 3 Yr. CAGR % | 4.43 | 27.23 | 11.41 | 6.38 | -12.06 | |||||
Inventory, 3 Yr. CAGR % | 5.15 | 20.12 | 9.46 | -2.11 | -9.02 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 5.05 | 0.38 | 2.04 | 2.25 | 1.52 | |||||
Total Assets, 3 Yr. CAGR % | 3.98 | 9.8 | 10.17 | 7.92 | 1.34 | |||||
Tangible Book Value, 3 Yr. CAGR % | 2.83 | 6.56 | 8.29 | 6.93 | 2.34 | |||||
Common Equity, 3 Yr. CAGR % | 2.83 | 6.56 | 8.29 | 6.93 | 2.34 | |||||
Cash From Operations, 3 Yr. CAGR % | -5.26 | 9.04 | 54.83 | -16.76 | -15.58 | |||||
Capital Expenditures, 3 Yr. CAGR % | -12.65 | -19.37 | 17.65 | 13.84 | 23.62 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -4.55 | 30 | 101.57 | -13.04 | -19.9 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -4.16 | 30.49 | 100.47 | -12.41 | -18.68 | |||||
Dividend Per Share, 3 Yr. CAGR % | 0 | 0 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.18 | 9.8 | 7.6 | 8.79 | 10.67 | |||||
Gross Profit, 5 Yr. CAGR % | 1.98 | 5.18 | 4.16 | -0.75 | 3.5 | |||||
EBITDA, 5 Yr. CAGR % | 13.1 | 15.26 | 8.21 | 4.61 | 7.69 | |||||
EBITA, 5 Yr. CAGR % | 14.2 | 16.33 | 8.32 | 2.94 | 8.33 | |||||
EBIT, 5 Yr. CAGR % | 14.2 | 16.33 | 8.32 | 2.94 | 8.33 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.97 | 15.51 | 7.82 | -0.74 | 5.37 | |||||
Net Income, 5 Yr. CAGR % | 8.48 | 14.15 | 0.44 | -8.69 | 2.78 | |||||
Normalized Net Income, 5 Yr. CAGR % | 4.42 | 13.29 | -0.95 | -4.4 | 5.87 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 8.48 | 14.15 | 0.44 | -8.69 | 2.78 | |||||
Accounts Receivable, 5 Yr. CAGR % | 13.39 | 6.56 | 4.59 | 11.82 | 3.95 | |||||
Inventory, 5 Yr. CAGR % | 5.87 | 6.97 | 4.72 | 3.57 | 4.45 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.56 | 3.51 | 3.44 | 1.66 | 1.61 | |||||
Total Assets, 5 Yr. CAGR % | 5.18 | 6.58 | 6.29 | 6.85 | 6.74 | |||||
Tangible Book Value, 5 Yr. CAGR % | 4.41 | 5.06 | 5.18 | 5.33 | 5.58 | |||||
Common Equity, 5 Yr. CAGR % | 4.41 | 5.06 | 5.18 | 5.33 | 5.58 | |||||
Cash From Operations, 5 Yr. CAGR % | 10.59 | 37.69 | 14.48 | -15.69 | 11.45 | |||||
Capital Expenditures, 5 Yr. CAGR % | 5.49 | -0.91 | -5.62 | -2.76 | 19.49 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 15.54 | 29.2 | 29.91 | -4.95 | 13 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 15.76 | 29.64 | 30.04 | -4.3 | 13.8 | |||||
Dividend Per Share, 5 Yr. CAGR % | 0 | 0 | 0 | 0 | 0 |
- Stock Market
- Equities
- SAB Stock
- Financials Southern Acids (M)
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















